February 9, 2011 – The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for enhanced software that automatically detects significant (50 percent and more) stenotic lesions in coronary arteries from coronary computed tomography angiography (CTA) studies. The COR Analyzer system, from Rcadia Medical Imaging, is designed to help speed detection of coronary artery disease.
